Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000007

Sr. VP & CSO sold 33,981 shares at an average $89.52 ($3,041,910)

  • Sr. VP & CSO gave up 6,993 shares (to pay taxes)
  • Sr. VP & CSO acquired 25,977 shares (option exercise)
  • Sr. VP & CSO acquired 15,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Or Yat Sun · Sr. VP & CSO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-11 Exercise or conversion : show line 1 in the form +10,249 $11.77 $120,631 320,169 D
2019-02-11 Exercise or conversion : show line 2 in the form +6,956 $14.00 $97,384 327,125 D
2019-02-11 Exercise or conversion : show line 3 in the form +8,772 $14.18 $124,387 335,897 D
2019-02-11 Sale : show line 4 in the form −5,835 $88.66 $517,321 330,062 D
2019-02-11 Sale : show line 5 in the form −18,971 $89.50 $1,697,878 311,091 D
2019-02-11 Sale : show line 6 in the form −2,707 $90.11 $243,936 308,384 D
2019-02-11 Sale : show line 7 in the form −171 $91.24 $15,602 308,213 D
2019-02-12 Sale : show line 8 in the form −6,297 $90.07 $567,173 301,916 D
Open-market sales · 33,981 sh · avg $89.52 · $3,041,910

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-11 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −10,249 $11.77 2022-06-20 10,249 3,672 D
2019-02-11 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −6,956 $14.00 2023-03-20 6,956 13,926 D
2019-02-11 Exercise or conversion : show line 14 in the form Stock Option (Right to Buy) −8,772 $14.18 2022-12-26 8,772 5,149 D
Loading xslF345X03/edgar.xml…